Prime Medicine (PRME) Change in Accured Expenses (2021 - 2026)

Prime Medicine's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$4.5 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 32.35% year-over-year to -$4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $993000.0 (up 394.66% YoY) and the FY2025 annual result came in at -$1.2 million, down 162.94% from the prior year.
• Change in Accured Expenses was -$4.5 million for Q1 2026 at Prime Medicine, down from $1.6 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.9 million in Q3 2024 and bottomed at -$33.3 million in Q1 2022.
• A 5-year average of -$1.6 million and a median of $608000.0 in 2023 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 1211.11% in 2025, while the deepest fall reached 118.06% in 2025.
• Prime Medicine's Change in Accured Expenses stood at $4.1 million in 2022, then sank by 38.53% to $2.5 million in 2023, then tumbled by 105.73% to -$144000.0 in 2024, then surged by 1211.11% to $1.6 million in 2025, then tumbled by 381.38% to -$4.5 million in 2026.
• Business Quant data shows PRME's Change in Accured Expenses at -$4.5 million in Q1 2026, $1.6 million in Q4 2025, and -$1.1 million in Q3 2025.